BioRem Inc.
BIRMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $31 | $36 | $42 | $48 |
| - Cash | $6 | $8 | $10 | $5 |
| + Debt | $3 | $3 | $3 | $4 |
| Enterprise Value | $28 | $31 | $35 | $47 |
| Revenue | $11 | $9 | $5 | $9 |
| % Growth | 19.3% | 99.4% | -49.2% | – |
| Gross Profit | $3 | $3 | $1 | $2 |
| % Margin | 28.1% | 27% | 23.5% | 17.1% |
| EBITDA | $2 | $1 | $0 | $0 |
| % Margin | 15.5% | 12.3% | 4.8% | 4.6% |
| Net Income | $1 | $1 | $0 | $0 |
| % Margin | 7.4% | 7.9% | 0.8% | 1.8% |
| EPS Diluted | 0.045 | 0.04 | 0.002 | -0.023 |
| % Growth | 11.5% | 1,900% | 108.5% | – |
| Operating Cash Flow | $1 | -$1 | $5 | -$2 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | -$2 | $5 | -$2 |